RIM
Ranger Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19
| Closed | -$3.74K | – | 92 |
|
|
2024
Q3 | $3.74K | Sell |
19
-23
| -55% | -$4.53K | ﹤0.01% | 87 |
|
|
2024
Q2 | $8.68K | Hold |
42
| – | – | ﹤0.01% | 84 |
|
|
2024
Q1 | $11.4K | Buy |
42
+16
| +62% | +$4.34K | ﹤0.01% | 80 |
|
|
2023
Q4 | $6.15K | Hold |
26
| – | – | ﹤0.01% | 92 |
|
|
2023
Q3 | $5.1K | Hold |
26
| – | – | ﹤0.01% | 93 |
|
|
2023
Q2 | $5.47K | Buy |
26
+9
| +53% | +$1.89K | ﹤0.01% | 92 |
|
|
2023
Q1 | $3.43K | Sell |
17
-3
| -15% | -$605 | ﹤0.01% | 94 |
|
|
2022
Q4 | $4.36K | Hold |
20
| – | – | ﹤0.01% | 91 |
|
|
2022
Q3 | $4K | Hold |
20
| – | – | ﹤0.01% | 92 |
|
|
2022
Q2 | $4K | Sell |
20
-5
| -20% | -$1K | ﹤0.01% | 92 |
|
|
2022
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 87 |
|
|
2021
Q4 | $9K | Hold |
25
| – | – | ﹤0.01% | 84 |
|
|
2021
Q3 | $10K | Hold |
25
| – | – | ﹤0.01% | 89 |
|
|
2021
Q2 | $9K | Sell |
25
-5
| -17% | -$1.8K | ﹤0.01% | 91 |
|
|
2021
Q1 | $9K | Buy |
30
+14
| +88% | +$4.2K | ﹤0.01% | 89 |
|
|
2020
Q4 | $4K | Sell |
16
-22
| -58% | -$5.5K | ﹤0.01% | 95 |
|
|
2020
Q3 | $9K | Hold |
38
| – | – | ﹤0.01% | 92 |
|
|
2020
Q2 | $7K | Sell |
38
-6
| -14% | -$1.11K | ﹤0.01% | 91 |
|
|
2020
Q1 | $6K | Hold |
44
| – | – | ﹤0.01% | 94 |
|
|
2019
Q4 | $7K | Buy |
44
+25
| +132% | +$3.98K | ﹤0.01% | 104 |
|
|
2019
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 108 |
|
|
2019
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 114 |
|
|
2019
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 109 |
|
|
2018
Q4 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 117 |
|